Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)

CUSIP: 471871202

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+12,456,253
Put/Call ratio
14%
SEC-reported price per share
$29.36
Number of holders
56
Value change
+$364,621,578
Number of buys
55
Open additional details 1 more signal available
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
33,902,298

Security key

471871202

Report period

Q1 2024

Institutions

56

Top holders

10

Ownership snapshot

Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Fernwood Investment Manag...
Disclosed value leader
Ally Bridge Group (NY) LLC
Comparable rows
1/15
Latest evidence
08 Feb 2024
13F 3/4/5 Lead comparable stake: 1.5% 14 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Fernwood Investment Management, LLC leads the comparable SEC ownership view at 1.5%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Fernwood Investment Management, LLC's linked filing trail.
Comparable ownership Top 1
Fernwood Investment Management, LLC 1.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Fernwood Investment Management, LLC
13F
Company
13F
1.5%
$390,323
494,706 shares
31 Dec 2023
Velan Capital Investment Management LP
3/4/5 13F
10%+ Owner · Company
class O/S missing
$18,568,073
1,433,828 shares
08 Feb 2024
Carlyle Group Inc.
3/4/5 13F
Former 10% Owner · Company
class O/S missing
$13,807,148
1,066,189 shares
08 Feb 2024
Qiming U.S. Healthcare Fund II, L.P.
3/4/5
10%+ Owner
class O/S missing
$5,525,844
8,519,648 shares
27 Jan 2023
ROCHE HOLDING LTD
3/4/5
10%+ Owner
class O/S missing
$2,950,874
4,549,606 shares
25 Jan 2023
Amplitude Healthcare Holdings LLC
3/4/5
10%+ Owner
class O/S missing
$1,491,780
2,300,000 shares
24 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
56
Shares
12,950,959
Rows available
56
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
56
Q1 2024 holders
56
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .